Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Lyell Wealth Management LP

Key Points

• Lyell Wealth Management LP increased its stake in Intuitive Surgical by 2.3%, now holding 34,487 shares valued at approximately $17.08 million, making it the fund's 14th largest position.
• Intuitive Surgical's stock has a market cap of $179.42 billion with a 1-year high of $616.00 and a low of $425.00, and last reported earnings beat estimates at $2.19 EPS.
• Insider selling activity included the sale of 4,500 shares by EVP Myriam Curet and 2,800 shares by Gary S. Guthart, with total insider sales over the last 90 days amounting to about $7.93 million.

Lyell Wealth Management LP grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,487 shares of the medical equipment provider's stock after buying an additional 778 shares during the quarter. Intuitive Surgical accounts for 1.6% of Lyell Wealth Management LP's portfolio, making the stock its 14th largest position. Lyell Wealth Management LP's holdings in Intuitive Surgical were worth $17,080,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ISRG. AlphaCore Capital LLC raised its holdings in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Accredited Investors Inc. boosted its holdings in shares of Intuitive Surgical by 1.9% in the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock worth $543,000 after buying an additional 19 shares during the last quarter. Second Line Capital LLC boosted its holdings in shares of Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after buying an additional 19 shares during the last quarter. Colonial Trust Co SC increased its holdings in Intuitive Surgical by 8.8% during the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock valued at $128,000 after buying an additional 20 shares during the last quarter. Finally, Crown Wealth Group LLC increased its holdings in Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,903 shares of company stock valued at $7,932,778 over the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.4%

Shares of NASDAQ ISRG traded up $2.03 during midday trading on Friday, hitting $483.12. The company's stock had a trading volume of 2,982,876 shares, compared to its average volume of 1,997,437. The firm has a market cap of $173.19 billion, a P/E ratio of 67.38, a price-to-earnings-growth ratio of 5.04 and a beta of 1.60. The business's 50 day moving average is $524.01 and its two-hundred day moving average is $533.35. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.78 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on ISRG shares. Citigroup reaffirmed a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Finally, UBS Group increased their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $592.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.